Non-specific anionic and hydrophobic surfaces

Non-specific anionic and hydrophobic surfaces refer to generalized physicochemical environments rather than specific molecular entities like receptors or enzymes (Seydel & Wiese, 2002). Anionic surfaces are often characterized by negatively charged components, such as phosphatidylglycerol in bacterial membranes or lipopolysaccharides, which attract cationic molecules through electrostatic forces (Zasloff, 2002). Hydrophobic surfaces include the non-polar interior of lipid bilayers and hydrophobic pockets on transport proteins like human serum albumin (Smith et al., 2010). These surfaces play a critical role in the pharmacokinetics of many drugs, as high affinity for these non-specific sites can lead to extensive protein binding or sequestration in fatty tissues (Boffey et al., 2021). While not traditional targets, they are the primary site of action for certain classes of drugs, such as antimicrobial peptides and lipopeptides like daptomycin, which disrupt membrane integrity (Humphries et al., 2013). However, interaction with these surfaces is frequently associated with off-target effects, such as hemolysis or nephrotoxicity, due to a lack of cellular specificity (Zasloff, 2002). In drug development, minimizing non-specific binding to these surfaces is often a key objective to improve the free fraction of a drug and its overall safety profile (Smith et al., 2010). Consequently, this term describes a broad category of interaction sites that influence drug distribution and toxicity rather than a discrete therapeutic target.

Other names

Non-specific binding sitesAnionic lipid membranesHydrophobic patchesNon-specific adsorption surfaces

Drugs interact via electrostatic attraction to anionic surface components followed by hydrophobic insertion into lipid bilayers or protein domains, leading to membrane disruption or non-specific sequestration (Zasloff, 2002; Seydel & Wiese, 2002).